RGS 0.00% 12.0¢ regeneus ltd

Ann: Patent granted for allogeneic stem cell technology platform, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 109 Posts.
    lightbulb Created with Sketch. 5
    Agree. I really like what RGS are doing. There are plenty of unhappy investors who have seen their shares tank since the CR, but I think we have hit the bottom and this now looks fantastic in terms of risk/reward. News flows are continuous and they are getting on with it. Announcement re Japan partnering would be well received by years end. Otherwise, results and progress updates on trials are just around the corner.
 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.